Cancer Cell

Papers
(The H4-Index of Cancer Cell is 107. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer2722
Long-range cholinergic input promotes glioblastoma progression673
Lymphoma accelerates T cell and tissue aging656
KIT as a therapeutic target in neuroendocrine prostate cancer496
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression474
Characterization of the generic mutant p53-rescue compounds in a broad range of assays433
TAMing immunity through an unexpected source423
A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture417
Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer408
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas385
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer345
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions340
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition338
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity337
Accelerated approvals: Early-phase success or premature authorization?320
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients309
Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling294
Diet-microbiome interactions in cancer290
Hand in hand to successful immunotherapy: CD8+ T cells and M1-like macrophages swap the baton288
Spatial profiling technologies illuminate the tumor microenvironment284
EGFR-activated myofibroblasts promote metastasis of pancreatic cancer281
Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations276
Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target274
T cell dynamism and immune-related adverse events273
T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation272
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma269
B cell heterogeneity in cancer comes of age264
Cancer vaccines256
The aging lung microenvironment awakens melanoma metastases255
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron254
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer249
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity232
Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses228
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses225
Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer223
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer214
Bacteria in metastatic sites: Unveiling hidden players in cancer progression208
Challenges in neoantigen-directed therapeutics206
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer203
A holistic view of cancer202
When the methylome becomes the microscope201
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments195
High endothelial venules in cancer: Regulation, function, and therapeutic implication194
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma193
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors191
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer186
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer180
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin176
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts175
A genetic portrait of metastatic seeds in lung adenocarcinoma174
Are we ready to look beyond plasma cells in assessing high-risk smoldering myeloma?172
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer172
Gut microbes promote chemoradiotherapy resistance via metabolic cross-feeding172
Tumor-directed dysregulation of erythroid progenitors drives immunosuppressive myeloid cells172
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population169
Challenges and opportunities for modeling aging and cancer169
Targeting STING to generate therapeutic anti-tumor immunity168
The one-two punch: TIM-3 blockade targets immune and tumor cells to knock out pediatric brain tumors167
Distinct T cell functions enable efficient immunoediting and prevent tumor emergence of developing sarcomas166
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation166
Immunosensitivity cuts across mismatch repair status in colorectal cancer164
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma163
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression161
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma161
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy159
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation159
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma155
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma152
Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer147
Hypoxia inducible factor-1α drives cancer resistance to cuproptosis145
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer143
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients140
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy140
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics138
Recognition of observer effect is required for rigor and reproducibility of preclinical animal studies137
Response-based molecular subtyping—emergence of the third generation of breast cancer subtypes136
Circulating tumor DNA as a biomarker in early phase clinical trials136
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers136
Midkine as a driver of age-related changes and increase in mammary tumorigenesis135
Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions134
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma134
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD132
A path to translation: How 3D patient tumor avatars enable next generation precision oncology131
Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring131
Immune determinants of the pre-metastatic niche130
Tumor-infiltrating lymphocytes: A new hope130
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness128
Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis128
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells127
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment127
Integrated proteogenomic characterization of glioblastoma evolution125
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1124
Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapy123
Taxanes directly induce T cell cytotoxic extracellular vesicles to eradicate tumor cells123
GDF15 research from bench to bedside123
The winner takes it all: Competition drives clonal selection in gliomagenesis120
Firing up neutrophil anti-tumor immunity with cocktails119
A circular RNA in neuroendocrine carcinomas119
JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma118
Tumors on different wavelengths118
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients—COVIDOUT study117
IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma116
Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial114
T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers113
New horizons at the interface of artificial intelligence and translational cancer research111
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma109
Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest108
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma107
Proteogenomic data and resources for pan-cancer analysis107
Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma107
Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance107
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer107
0.47632098197937